Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Refractory heart failure.

J B Young1

  • 1Section of Heart Failure and Cardiac Transplant Medicine, Department of Cardiology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk F-25, Cleveland, OH 44195, USA.

Current Cardiology Reports
|September 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Patient Reported Experience Measure (PREM) for use by older people in community services.

Age and ageing·2015
Same author

Epidermal growth factor and parathyroid hormone-related peptide mRNA in the mammary gland and their concentrations in milk: effects of postpartum hypoxia in lactating rats.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2008
Same author

Developmental origins of obesity: a sympathoadrenal perspective.

International journal of obesity (2005)·2006
Same author

Survival beyond 10 years following heart transplantation: The Cleveland Clinic Foundation experience.

Transplantation proceedings·2006
Same author

Asymptomatic LV systolic dysfunction was more than twice as prevalent as symptomatic LV systolic dysfunction.

Evidence-based cardiovascular medicine·2005
Same author

Home-based intervention strategy was superior to usual care in discharged CHF patients.

Evidence-based cardiovascular medicine·2005

Effective heart failure management requires early recognition and tailored therapies. Advanced stages necessitate aggressive interventions, including novel drugs and radical treatments, based on individual patient needs.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Heart failure (HF) management hinges on accurate diagnosis and stage-specific treatment.
  • Asymptomatic left ventricular dysfunction differs significantly in management from advanced HF with fluid retention and organ hypoperfusion.

Purpose of the Study:

  • To outline the principles of tailoring heart failure therapies to individual patient stages.
  • To review the spectrum of available treatments for advanced heart failure.

Main Methods:

  • Literature review of current heart failure management strategies.
  • Analysis of therapeutic options based on disease severity and patient clinical circumstances.

Main Results:

  • Early-stage HF requires different approaches than advanced stages.

Related Experiment Videos

  • Advanced HF management involves pharmacologic interventions, parenteral inotropic therapy, dialysis, ventricular assist devices, cardiac transplantation, myoplasty, and surgery.
  • New drug evaluations offer potential for improved advanced HF therapies.

    • Conclusions:

    • Recognizing the appropriate stage of heart failure is crucial for treatment selection.
    • Individualized, aggressive strategies are essential for managing advanced heart failure.
    • The judicious application of radical therapies can improve outcomes in select patients.